Navigation Links
Catabasis Closes $32.4 Million Series B Financing
Date:11/14/2013

CAMBRIDGE, Mass., Nov. 15, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals, Inc., today announced it has completed a $32.4 million Series B financing round led by new investor Lightstone Ventures. A leading public crossover fund and all current Catabasis investors, including SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures, also participated in the financing.

"This investment reflects our confidence in Catabasis' pipeline of SMART Linker conjugates as much as our belief in management's ability to successfully advance its clinical candidates," said Jean George, partner of Lightstone Ventures. "Catabasis has achieved a number of important milestones in the past year including positive data from Phase 1 studies of both CAT-2003 and CAT-1004. We look forward to working with the management team as they complete the ongoing Phase 2 trial for CAT-2003 and seek to advance the rest of the pipeline."

Catabasis plans to use proceeds from this financing to support the development of its lead compound, CAT-2003, a modulator of the lipid synthesis pathway, which is currently in a Phase 2 clinical trial in patients with hypertriglyceridemia and in combination with statins in patients with hypercholesterolemia. Catabasis also plans to use the proceeds to support the continued clinical and pre-clinical development of other SMART Linker conjugates in the pipeline.

"We are tremendously excited about the progress we've made with our pipeline thus far, having reported positive Phase 1 data for both CAT-2003 and CAT-1004 and having advanced CAT-2003 to Phase 2," said Jill Milne, Ph.D., co-founder and chief executive officer of Catabasis. "This financing enables Catabasis to continue to execute on the promise of its pipeline for dyslipidemias and diseases involving chronic inflammation."  '/>"/>

SOURCE Catabasis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
2. Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
3. Catabasis Names Ian Sanderson Chief Financial Officer
4. Independa Closes Convertible Note Funding at $2.35 Million
5. Stereotaxis Closes $18.5 Million Private Placement Financings
6. Boston Scientific Closes Cameron Health Acquisition
7. C8 MediSensors Closes $19 million Preferred Stock Financing
8. Igenica Closes $33 Million in Series C Funding
9. BONESUPPORT Closes Second Tranche of Funding
10. PTC Therapeutics Closes $30 Million Financing
11. Chiasma Closes $38.5 Million Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... of a new generation of drugs within human ... established a sales company in the ... for Paccal Vet-CA1, its leading companion animal therapeutic. ...      (Photo: http://photos.prnewswire.com/prnh/20150703/228329 ) , ...
(Date:7/7/2015)... , July 7, 2015   Mallinckrodt plc ... results on Tuesday, August 4, 2015. A conference call for ...   The call can be accessed in ... http://www.mallinckrodt.com/investors . , By telephone: For both listen-only participants ... portion of the call, the telephone dial-in number in the ...
(Date:7/7/2015)... 7, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... non-binding Letter of Intent (LoI) for an investment and ... Sinopharm Capital Management Co. Ltd. and Hefei Life Science ... Hefei ) potentially valued at $50,000,000 plus ...
Breaking Medicine Technology:Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Mallinckrodt plc To Report Third Quarter Fiscal 2015 Results On August 4, 2015 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 3Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 4Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 5
... (NYSE: BSX ) is scheduled to present at ... Ray Elliott, President and Chief Executive Officer, will ... at approximately 9:30 a.m. PT.  Following the presentation, Jeff Capello, ... Elliott in a question and answer session. A ...
... Calif., Dec. 27, 2010 King Pharmaceuticals®, Inc. ... PTIE ) today announced that King has resubmitted ... U.S. Food and Drug Administration (FDA) in response to a ...  This is a Class 2 resubmission with a six month ...
Cached Medicine Technology:King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 2King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 3
(Date:7/7/2015)... ... July 07, 2015 , ... Isabel ... jointly announced a partnership focused on providing knowledge organizing and differential diagnostic support ... will be conducted with NIWH trained patient health educators, utilizing the Knowledge Organizer ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... announce the launch of their new website, the Invokana Ketoacidosis Lawsuit Center ... warning*, and serves as a resource for persons wishing to learn more about ...
(Date:7/7/2015)... ... 2015 , ... CareSync proudly announces today that Amy Gleason, ... House as a “Champion of Change” for Precision Medicine on Wednesday, July 8th. ... Change program recognizes Gleason and eight other extraordinary individuals who are making great ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing ... of AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs ... detection technologies and genetic engineering also open lucrative opportunities for the market players. ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... “ TapGlance ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this interior design app helps users visualize what rooms ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2
... suffered from depression before the diagnosis, , , FRIDAY, May ... than twice as likely to develop post-traumatic stress disorder ... new research suggests. , About 16 percent of the ... Ohio State University Medical experienced PTSD 18 months after ...
... Force,Colonel Mike Turner, a Democratic candidate for U.S. Congress ... inspired by MSNBC host,Keith Olbermann. Today is the 169th ... key architect of Hillary Clinton,s,notorious 1993 health care plan, ... 10th District voters what, if any, plan she has ...
... Calif., May 9 Dakim, Inc., announced,today that ... in,health and fitness, has signed on as a ... [m]Power Cognitive Fitness System, joining the,company,s efforts to ... is a touch screen-based brain workout program designed,to ...
... provide more visible presence for world,s largest surgical,organization, ... today broke ground for a new home for its ... on Capitol Hill. The,10-story, class A office building, located ... first quarter of 2010. ACS headquarters will remain in ...
... ,SELF MEDICATION, FOR DEPRESSION LEADS TO MORE SERIOUS MENTAL ILLNESS, ... ... to Relieve Symptoms, WASHINGTON, May 9 Millions of American teens ... many of these depressed teens are using marijuana and other,drugs, making their ...
... 2008 As controversy swirls about proper clinical use of ... American Pain Society annual meeting shows that, contrary to widespread ... of drug abuse who are prescribed opioids for chronic pain ... , In his plenary session address, Srinivasa ...
Cached Medicine News:Health News:Mood Disorders Put Breast Cancer Patients at Risk for PTSD 2Health News:Mike Turner, Virginia Congressional Candidate, Starts Healthcare Countdown 2Health News:Physical Fitness 'Godfather' Jack LaLanne Turns to Brain Fitness, Becoming Ambassador for Dakim's [m]Power System 2Health News:American College of Surgeons Breaks Ground on New Office Building on Capitol Hill 2Health News:White House Office of National Drug Control Policy National Youth Anti-Drug Media Campaign 2Health News:White House Office of National Drug Control Policy National Youth Anti-Drug Media Campaign 3Health News:Risks for painkiller abuse do not outweigh benefits in chronic pain 2
... Perfect Single Vac Manifold is ... plate in 30 minutes; the ... "open/closed" switch and a vacuum ... operation. contains vacuum chamber, on/off ...
... The TurboVap Concentration Workstations from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen ... in use around the world today. ... ... ...
Plastic Tray Type Vacuum Manifold...
... Vacuum Manifold system for sample processing consists ... a vacuum is applied, a chemical-resistant polypropylene ... convenience in sample handling. The manifold is ... up to 12 samples simultaneously. Loading, washing, ...
Medicine Products: